| Catalog # | Availability | Size | Quantity | Unit Price | Save For Later Wish List | |
|---|---|---|---|---|---|---|
| CYK0186-20 | 7 days | 20 µg | $120.00 |
Select product before adding to cart
|
||
| CYK0186-100 | 7 days | 100 µg | $290.00 | |||
| CYK0186-1 | 7 days | 1 mg | $1,440.00 |
Product Overview | |
| Name | IFN a 2a Human |
|---|---|
| Description | |
| IFN-Alpha 2a Human Recombinant | |
| Accession (Primary) | P01563 |
| Synonyms | |
| Leukocyte interferon, B cell interferon, Type I interferon, IFNA2, IFN-a 2a. | |
| Introduction | |
| IFN-alpha is produced by macrophages and has antiviral activities. Interferon stimulates the production of two enzymes: protein kinase and an oligoadenylate synthetase. | |
| Source | |
| Nicotiana Sp.Plant. | |
| Physical Appearance | |
| Sterile Filtered White lyophilized (freeze-dried) powder. | |
| Formulation | |
| Lyophilized, containing 50% SDS. | |
| Stability | |
| Lyophilized Interferon alpha 2a although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution IFN-alpha 2a should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. | |
| Purity | |
| Greater than 99.0% as determined by both: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. | |
| Amino acid sequence | |
| The sequence of the first twelve N-terminal amino acids was determined and was found to be Cys-Asp-Leu-Pro-Gln-Thr-His-Ser-Leu-Gly-Ser-Arg. | |
| Biological Activity | |
| The specific activity was determined by a quantitative gene report bioassay using human Type I interferon-sensitive cells. Compared with bacterial derived recombinant IFN-a 2a, assayed in the same conditions, plant derived IFN-alpha 2a showed 6.1 × 10 8 Units/mg in reference to a viral resistance assay using bovine kidney MDBK cells. | |
| Solubility | |
| It is recommended to reconstitute the lyophilized Interferon-alpha 2a in sterile 18MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions. | |
| Precautions | |
| IFN a 2a Human is for research use only and not for use in diagnostic or therapeutic procedures. | |
Target Information: ( P01563 ) | |
References |
1. Title :Gender specificity of altered human immune cytokine profiles in aging. Publication :Published online before print May 7, 2010, doi: 10.1096/fj.10-160911 September 2010 The FASEB Journal vol. 24 no. 9 3580-3589 Link: IFN a 2a prospec publication 2. Title: Differential involvement of 5-HT1A and 5-HT1B/1D receptor in human IFN a-induced immobility Publication: Arzneimittel-Forschung 60.3 (2009): 109-115. Link: IFN-Alpha 2a prospec publication |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from ADMEbio to advance their research.
Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
Thank you,
ADMEbio Team
ADMEbio welcomes feedback from our customers.
Thank you,
ADMEbio Team